Rating Change
Wells Fargo reiterated its Equal-Weight rating on Oscar Health, Inc. (NYSE:OSCR) on August 13, 2026.
Wells Fargo reiterated its Equal-Weight rating on Oscar Health, Inc. (NYSE:OSCR) on August 13, 2026.

At publication ·
Oscar Health, Inc. (NYSE:OSCR) · reiterate
At a glance
Wells Fargo reiterated its Equal-Weight rating on Oscar Health, Inc. (NYSE:OSCR) on August 13, 2026.
Oscar Health, Inc. operates in the Healthcare sector. The stock currently trades at $29.91 with a market capitalization of $4.1B.
Analyst coverage from Wells Fargo provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Oscar Health, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Among the 10 most recent ratings: 2 Buy, 8 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 13, 2026 | Wells Fargo | Equal-Weight | N/A |
| Aug 07, 2026 | Barclays | Overweight | N/A |
| Aug 07, 2026 | UBS | Neutral | N/A |
| Jun 10, 2026 | Barclays | Overweight | N/A |
| May 26, 2026 | Barclays | Equal-Weight | N/A |
Related Tools: Analyst Ratings Dashboard | View OSCR Stock Page
A rating of Equal-Weight from Wells Fargo reflects the analyst's outlook on Oscar Health, Inc. (NYSE:OSCR). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the OSCR forecast page.
Current market data
NYSE · OSCR
$30.78
Up: +$1.17 · +3.95%
Live quote updated
Keep reading